Cargando…
Factors associated with bleeding events from enoxaparin used for patients with acute coronary syndrome
BACKGROUND: Low molecular weight heparins (LMWHs) are the mainstay of treatment for acute coronary syndrome (ACS). However, bleeding, the main side effect, is associated with prolonged hospitalization and mortality. Therefore, assessment of the incidence of bleeding and associated risk factors is cr...
Autores principales: | Weerasaksanti, Adisak, Siwamogsatham, Sarawut, Kunlamas, Yotsaya, Bunditanukul, Krittin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164346/ https://www.ncbi.nlm.nih.gov/pubmed/37149613 http://dx.doi.org/10.1186/s12872-023-03278-9 |
Ejemplares similares
-
The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial
por: Susomboon, Teerada, et al.
Publicado: (2022) -
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial
por: Zhou, Shenghua, et al.
Publicado: (2023) -
Enoxaparin sodium: Minor bleeding: case report
Publicado: (2021) -
Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design
por: Gurfinkel, Enrique P, et al.
Publicado: (2004) -
Dual Prosthetic Heart Valve Presented with Chest Pain: A Case Report of Coronary Thromboembolism
por: Wongrakpanich, Supakanya, et al.
Publicado: (2015)